Literature DB >> 20831921

Alzheimer disease.

Rudy J Castellani, Raj K Rolston, Mark A Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20831921      PMCID： PMC2941917          DOI： 10.1016/j.disamonth.2010.06.001

Source DB:  PubMed          Journal:  Dis Mon        ISSN： 0011-5029            Impact factor:   3.800


× No keyword cloud information.
  296 in total

1.  Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.

Authors:  G Li; E B Larson; J A Sonnen; J B Shofer; E C Petrie; A Schantz; E R Peskind; M A Raskind; J C S Breitner; T J Montine
Journal:  Neurology       Date:  2007-08-28       Impact factor: 9.910

2.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

3.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

4.  Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease.

Authors:  D J Selkoe; C R Abraham; M B Podlisny; L K Duffy
Journal:  J Neurochem       Date:  1986-06       Impact factor: 5.372

5.  Age and histopathologic heterogeneity in Alzheimer's disease. Evidence for subtypes.

Authors:  W Bondareff; C Q Mountjoy; M Roth; M N Rossor; L L Iversen; G P Reynolds
Journal:  Arch Gen Psychiatry       Date:  1987-05

Review 6.  Education and the prevalence of dementia and Alzheimer's disease.

Authors:  R Katzman
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

Review 7.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

8.  Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles.

Authors:  R Natté; M L Maat-Schieman; J Haan; M Bornebroek; R A Roos; S G van Duinen
Journal:  Ann Neurol       Date:  2001-12       Impact factor: 10.422

9.  Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease.

Authors:  M Eriksdotter Jönhagen; A Nordberg; K Amberla; L Bäckman; T Ebendal; B Meyerson; L Olson; M Shigeta; E Theodorsson; M Viitanen; B Winblad; L O Wahlund
Journal:  Dement Geriatr Cogn Disord       Date:  1998 Sep-Oct       Impact factor: 2.959

10.  Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.

Authors:  Peter P Zandi; James C Anthony; Ara S Khachaturian; Stephanie V Stone; Deborah Gustafson; JoAnn T Tschanz; Maria C Norton; Kathleen A Welsh-Bohmer; John C S Breitner
Journal:  Arch Neurol       Date:  2004-01
View more
  129 in total

Review 1.  Cell cycle deregulation in the neurons of Alzheimer's disease.

Authors:  Calvin Moh; Jacek Z Kubiak; Vladan P Bajic; Xiongwei Zhu; Mark A Smith; Hyoung-Gon Lee
Journal:  Results Probl Cell Differ       Date:  2011

2.  Cognitive profiles in heart failure: a cluster analytic approach.

Authors:  Lindsay A Miller; Mary Beth Spitznagel; Michael L Alosco; Ronald A Cohen; Naftali Raz; Lawrence H Sweet; Lisa Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  J Clin Exp Neuropsychol       Date:  2012-03-01       Impact factor: 2.475

Review 3.  Synthetic nucleic acids delivered by exosomes: a potential therapeutic for generelated metabolic brain diseases.

Authors:  Rutao Liu; Jing Liu; Xiaofei Ji; Yang Liu
Journal:  Metab Brain Dis       Date:  2013-12       Impact factor: 3.584

4.  Regional analysis of the magnetization transfer ratio of the brain in mild Alzheimer disease and amnestic mild cognitive impairment.

Authors:  M Mascalchi; A Ginestroni; V Bessi; N Toschi; S Padiglioni; S Ciulli; C Tessa; M Giannelli; L Bracco; S Diciotti
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-06       Impact factor: 3.825

5.  Pomegranate inhibits neuroinflammation and amyloidogenesis in IL-1β-stimulated SK-N-SH cells.

Authors:  Ravikanth Velagapudi; Gina Baco; Sunjeet Khela; Uchechukwu Okorji; Olumayokun Olajide
Journal:  Eur J Nutr       Date:  2015-07-10       Impact factor: 5.614

6.  Blood-CNS barrier, neurodegeneration and neuroprotection: recent therapeutic advancements and nano-drug delivery.

Authors:  Hari S Sharma
Journal:  J Neural Transm (Vienna)       Date:  2011-01       Impact factor: 3.575

Review 7.  Human CALHM5: Insight in large pore lipid gating ATP channel and associated neurological pathologies.

Authors:  Eijaz Ahmed Bhat; Nasreena Sajjad; Saeed Banawas; Johra Khan
Journal:  Mol Cell Biochem       Date:  2021-06-05       Impact factor: 3.396

Review 8.  Getting to the Heart of Alzheimer Disease.

Authors:  Joshua M Tublin; Jeremy M Adelstein; Federica Del Monte; Colin K Combs; Loren E Wold
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

9.  Neuroprotective effects of phenylethanoid glycosides in an in vitro model of Alzheimer's disease.

Authors:  Jianhua Yang; Bowei Ju; Yao Yan; Huanhuan Xu; Shanshan Wu; Dandan Zhu; Dandan Cao; Junping Hu
Journal:  Exp Ther Med       Date:  2017-03-22       Impact factor: 2.447

10.  Fused Group Lasso Regularized Multi-Task Feature Learning and Its Application to the Cognitive Performance Prediction of Alzheimer's Disease.

Authors:  Xiaoli Liu; Peng Cao; Jianzhong Wang; Jun Kong; Dazhe Zhao
Journal:  Neuroinformatics       Date:  2019-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.